Literature DB >> 33505115

The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1.

Shengpeng Zhang1, Fengge Zhang2, Limin Feng1.   

Abstract

Secreted protein acidic and rich in cysteines-like 1 (SPARCL1) is implicated in tumor progression and considered as a tumor suppressor. Aim of the study is to investigate the role of SPARCL1 in the regulation of tumor biology. SPARCL1 expression in human cervical cells was determined through western blot and RT-PCR. The effects of SPARCL1 overexpression on cell proliferation, migration and invasion were evaluated through CCK8 assay, colony formation assay, Wound healing assay and Transwell assay, respectively. The gain function of Secreted phosphor protein 1 (SPP1) was also evaluated in these cell functions. We observed that SPARCL1 expression at protein levels and transcription levels was lower in HeLa cells than that in Ect1/E6E7 cells. When SPARCL1 was overexpressed in HeLa cells, cell proliferation, migration and invasion were greatly repressed. Additionally, SPARCL1 overexpression markedly downregulated SPP1 expression at transcription levels. Mechanistical study revealed that SPP1 overexpression could greatly counteract the effects of SPARCL1 overexpression on the aforementioned cell processes and inhibit the phosphorylation of focal adhesion kinase (FAK) and extracellular regulated protein kinases (ERK). Our findings indicated that HeLa cells overexpressing SPARCL1 showed weaker abilities of proliferation, migration and invasion, and its effects could be neutralized by SPP1 overexpression possibly via FAK/ERK pathway. The relationship of SPARCL1 and SPP1 could help us to further understand the pathogenesis of cervical cancer and SPARCL1/SPP1 could be beneficial therapeutic targets in cervical cancer.
© The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021.

Entities:  

Keywords:  Cervical cancer; FAK/ERK; SPARCL1; SPP1

Year:  2021        PMID: 33505115      PMCID: PMC7817754          DOI: 10.1007/s10616-020-00443-2

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  16 in total

1.  SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.

Authors:  Xing Chen; Dongsheng Xiong; Liya Ye; Huichun Yang; Shuangshuang Mei; Jinhong Wu; Shanshan Chen; Ruoran Mi
Journal:  Cancer Chemother Pharmacol       Date:  2019-01-09       Impact factor: 3.333

2.  SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling.

Authors:  Yan Ma; Yuan Xu; Li Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

Review 3.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

Review 4.  Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.

Authors:  Ekambaram Shanthi; Mudeenahally H Krishna; Gubbi M Arunesh; K Venkateswara Reddy; Jegatheesan Sooriya Kumar; Vellarkad N Viswanadhan
Journal:  Expert Opin Ther Pat       Date:  2014-08-12       Impact factor: 6.674

5.  CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.

Authors:  Mei Zhang; Longjun Zhao
Journal:  DNA Cell Biol       Date:  2017-09-21       Impact factor: 3.311

6.  Osteopontin expression correlates with invasiveness in cervical cancer.

Authors:  Jae Yun Song; Jae Kwan Lee; Nak Woo Lee; Bom Woo Yeom; Sun Haeng Kim; Kyu Wan Lee
Journal:  Aust N Z J Obstet Gynaecol       Date:  2009-08       Impact factor: 2.100

7.  Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.

Authors:  Dong-Ming Wu; Jiao Shi; Teng Liu; Shi-Hua Deng; Rong Han; Ying Xu
Journal:  Cancer Biomark       Date:  2018-02-06       Impact factor: 4.388

8.  Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.

Authors:  Ying Liang; Tianli Zhang; Mengdie Shi; Shuo Zhang; Yaxing Guo; Jiwei Gao; Xingsheng Yang
Journal:  J Cell Biochem       Date:  2018-10-18       Impact factor: 4.429

Review 9.  The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review.

Authors:  Natalia Serrano Doratioto Faria Braz; Noely Paula Cristina Lorenzi; Isabel Cristina Esposito Sorpreso; Lana Maria de Aguiar; Edmund Chada Baracat; José Maria Soares-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2017-03       Impact factor: 2.365

10.  Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.

Authors:  Yuan-Yuan Qiang; Chang-Zhi Li; Rui Sun; Li-Sheng Zheng; Li-Xia Peng; Jun-Ping Yang; Dong-Fang Meng; Yan-Hong Lang; Yan Mei; Ping Xie; Liang Xu; Yun Cao; Wen-Wen Wei; Li Cao; Hao Hu; Qin Yang; Dong-Hua Luo; Ying-Ying Liang; Bi-Jun Huang; Chao-Nan Qian
Journal:  J Exp Clin Cancer Res       Date:  2018-02-20
View more
  3 in total

1.  Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p.

Authors:  Hang Li; Chang Yao; Kaihu Shi; Yang Zhao; Jin Du; Dinghui Hu; Zuntao Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Based on Molecular Subtypes, Immune Characteristics and Genomic Variation to Constructing and Verifying Multi-Gene Prognostic Characteristics of Colorectal Cancer.

Authors:  Lei Gu; Chunhui Jiang; Chunjie Xu; Ye Liu; Hong Zhou
Journal:  Front Cell Dev Biol       Date:  2022-02-23

3.  Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes.

Authors:  Cheng Xiao; Hai Guo Jin; Li Chun Zhang; Jian Qiang Liu; Ming He; Hui Hai Ma; Yong Sheng Yu; Yang Cao
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.